SCHEMBL285177

SCHEMBL285177

CCCCCCCCCCCCCCCC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.73
TSHR P16473 1/20 0.46
MAPT P10636 1/20 0.46
PMP22 Q01453 1/20 0.46
HBB P68871 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
P2RY6 Q15077 2/20 0.36
P2RY14 Q15391 2/20 0.36
PLA2G1B P04054 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
NT5E P21589 1/20 0.36
XDH P47989 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ADK P55263 3/20 0.36
DEGS1 O15121 1/20 0.35
SPHK2 Q9NRA0 1/20 0.35
SPHK1 Q9NYA1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9218042 1.00 LMNA (0.73) LMNATSHRMAPTPMP22HBB
SCHEMBL9217869 1.00 LMNA (0.73) LMNATSHRMAPTPMP22HBB
SCHEMBL9221413 1.00 LMNA (0.73) LMNATSHRMAPTPMP22HBB
SCHEMBL9220839 1.00 LMNA (0.73) LMNATSHRMAPTPMP22HBB
SCHEMBL285495 1.00 LMNA (0.73) LMNATSHRMAPTPMP22HBB
SCHEMBL9220711 1.00 LMNA (0.73) LMNATSHRMAPTPMP22HBB
SCHEMBL285088 1.00 LMNA (0.73) LMNATSHRMAPTPMP22HBB
SCHEMBL285382 1.00 LMNA (0.73) LMNATSHRMAPTPMP22HBB
SCHEMBL285493 1.00 LMNA (0.73) LMNATSHRMAPTPMP22HBB
SCHEMBL285266 0.99 LMNA (0.75) LMNATSHRMAPTPMP22HBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428213-A1 STABILIZED CHLORITE SOLUTIONS IN COMBINATION WITH FLUOROPYRIMIDINES FOR USE IN CANCER TREATMENT Nuvo Research AG (CH) 2012-03-14 EP claimed
EP-0316704-B1 Fluorocytidine derivatives, their preparation and medical preparations containing them HOFFMANN LA ROCHE (CH) 1995-07-12 EP claimed
EP-0316704-A2 Fluorocytidine derivatives, their preparation and medical preparations containing them F. HOFFMANN-LA ROCHE AG (CH) 1989-05-24 EP claimed
EP-2428213-A1 STABILIZED CHLORITE SOLUTIONS IN COMBINATION WITH FLUOROPYRIMIDINES FOR USE IN CANCER TREATMENT Nuvo Research AG (CH) 2012-03-14 EP disclosed
EP-0602478-B1 Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives HOFFMANN LA ROCHE (CH) 1996-07-31 EP disclosed
EP-0316704-B1 Fluorocytidine derivatives, their preparation and medical preparations containing them HOFFMANN LA ROCHE (CH) 1995-07-12 EP disclosed
EP-0602478-A1 Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1994-06-22 EP disclosed
EP-0316704-A2 Fluorocytidine derivatives, their preparation and medical preparations containing them F. HOFFMANN-LA ROCHE AG (CH) 1989-05-24 EP disclosed